The company uses a unique platform to identify rational combinations of immunotherapies and novel targets. (iteostherapeutics.com)
But even more important is to understand the mechanisms sufficiently enough to be able to come up with rational combination therapies to increase both the frequency of benefit and the duration of benefit from PARP inhibitors. (cancernetwork.com)
iTeos has developed an innovative phenotypic screening platform that is applied to the identification of rational combinations for our current programs, and to the discovery of novel targets for immuno - oncology. (iteostherapeutics.com)